The Business Times
business-time-50
SUBSCRIBERS

Peter Lim to inject healthcare assets into Rowsley

google-preferred-sourceAdd BT as a preferred source
Published Tue, Jul 18, 2017 · 09:50 PM

    Singapore

    REAL estate and investment firm Rowsley said on Tuesday night that controlling shareholder, Singapore billionaire Peter Lim, will be injecting his 100 per cent stake in Thomson Medical Pte Ltd and 70.36 per cent stake in Bursa Malaysia-listed TMC Life Sciences (TMCLS) into the firm.

    The proposed acquisitions are valued at up to S$1.9 billion, and will be financed through up to 25.3 billion consideration shares issued by Rowsley to Mr Lim at S$0.075 a share.

    TRENDING NOW

    The CSRC is leading the effort, along with the National Financial Regulatory Administration, which handles consumer protection and supervises banks.

    Why China is tightening controls on overseas stock trading

    US President Donald Trump with President Xi Jinping after a visit to Zhongnanhai Garden in Beijing, on May 15.

    Xi Jinping has just rewritten the rules of US-China rivalry

    Always one to walk the talk, DBS CEO Tan Su Shan has her personal AI agent that checks and serves up to her the latest news on banking.

    ‘Even a CEO’s job can be replaced by AI’: DBS CEO Tan Su Shan bets big on agentic AI

    Set up by Nichol Ng and her brother, FoodXervices traces its roots to 1934 with the business their grandfather started.

    ‘Whole deck of cards just toppled’: FoodXervices’ Nichol Ng on how a 92-year-old family business unravelled – and what’s next

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More